within Pharmacolibrary.Drugs.D_Dermatologicals.D10B_AntiAcnePreparationsForSystemicUse.D10BX01_Ichtasol;

model Ichtasol
  extends Pharmacolibrary.Drugs.ATC.D.D10BX01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D10BX01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ichthammol (ichtasol) is a complex mixture derived from sulfonated shale oil, historically used as a topical treatment for various dermatological conditions, including acne, eczema, psoriasis, and furunculosis. It is not systemically administered and is generally not used as a first-line or routine therapy today. Ichthammol is not approved for systemic use and remains primarily for topical application, mainly in Europe and some other countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data are available for ichtasol (ichthammol) since it is intended exclusively for topical application and not for systemic administration. All PK values below are estimated placeholders due to lack of systemic pharmacokinetic studies.</p><h4>References</h4><ol><li><p>Ong, RR, &amp; Goh, CF (2024). Niacinamide: a review on dermal delivery strategies and clinical evidence. <i>Drug delivery and translational research</i> 14(12) 3512–3548. DOI:<a href=\"https://doi.org/10.1007/s13346-024-01593-y\">10.1007/s13346-024-01593-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38722460/\">https://pubmed.ncbi.nlm.nih.gov/38722460</a></p></li><li><p>Gorouhi, F, &amp; Maibach, HI (2009). Role of topical peptides in preventing or treating aged skin. <i>International journal of cosmetic science</i> 31(5) 327–345. DOI:<a href=\"https://doi.org/10.1111/j.1468-2494.2009.00490.x\">10.1111/j.1468-2494.2009.00490.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19570099/\">https://pubmed.ncbi.nlm.nih.gov/19570099</a></p></li><li><p>Irvine, J, et al., &amp; Islam, N (2018). Formulation and delivery strategies of ibuprofen: challenges and opportunities. <i>Drug development and industrial pharmacy</i> 44(2) 173–183. DOI:<a href=\"https://doi.org/10.1080/03639045.2017.1391838\">10.1080/03639045.2017.1391838</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29022772/\">https://pubmed.ncbi.nlm.nih.gov/29022772</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ichtasol;
